Breaking News

Financial Report: WuXi PharmaTech 3Q11

Manufacturing revenues up 184%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech 3Q11 3Q Revenues: $104.0 million (+24%) 3Q Earnings: $20.6 million  (-53%) YTD Revenues: $298.6 million (+22%) YTD Earnings: $57.5 million (-22%) Comments: Manufacturing services revenues grew 184% in the quarter to $20.1 million, driven by large-scale commercial manufacturing and demand for clinical-trial materials. Laboratory services revenues grew 9% to $83.9 million, and China-based laboratory services increased 11% to $63.2 million, driven by strong growth in medicinal ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters